In the long-term, prostate cancer patient quality of life is comparable after ultra-hypofractionated and conventional radiotherapy

Phase II study does not show a survival benefit for use of bevacizumab alongside osimertinib in patients with advanced EGFR-mutated non-small-cell lung cancer

Meta-analysis has found a small risk of myelodysplastic syndrome and acute myeloid leukaemia in cancer patients given PARP inhibitors

Radiological and CA125 responses to neoadjuvant chemotherapy alone do not accurately identify epithelial ovarian cancer patients who will benefit from delayed primary surgery 

Patients with rectal cancer and a sustained clinical complete response after neoadjuvant chemotherapy may not need intensive surveillance after 3 years

Patients diagnosed with appendiceal cancer before the age of 50 years display different gene variants to individuals who develop this cancer later in life

An experimental treatment protocol of short-course radiotherapy plus preoperative chemotherapy may reduce treatment failure in locally advanced rectal adenocarcinoma

For lymph node-positive breast cancer patients, the RISAS trial’s targeted approach might avoid the need for axillary lymph node dissection after neoadjuvant chemotherapy